Patents by Inventor Michael Maragoudakis

Michael Maragoudakis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD, ELECTRONIC DEVICE AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM FOR DETERMINING INDOOR RADIO TRANSMITTER DISTRIBUTION
    Publication number: 20230059954
    Abstract: Embodiments of the disclosed techniques disclose methods for planning an indoor radio network for a building. In one embodiment, a method comprises preprocessing an image of a floor plan of the building; generating a radio propagation map for the floor plan using the preprocessed image; and determining an indoor radio transmitter distribution for the floor plan using the radio propagation map.
    Type: Application
    Filed: May 11, 2020
    Publication date: February 23, 2023
    Applicant: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Taesuh PARK, Chun-Hao LIU, Hun CHANG, Joji PHILIP, Thalanayar MUTHUKUMAR, Michael MARAGOUDAKIS
  • Parstatin peptides
    Patent number: 9180163
    Abstract: The present invention relates to parstatin peptides, compositions comprising parstatin peptides and their use in the treatment of various disorders, including angiogenesis-related diseases, ocular neovascularization and related disease states, ischemia-reperfusion injury and myocardial-related disease states, and renal disorders.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 10, 2015
    Inventors: Nikos Tsopanoglou, Michael Maragoudakis, Dimitrios Siablis
  • 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
    Patent number: 8563586
    Abstract: The present invention provides novel 1,5 and 1,3,5-substituted imidazole compounds in hydrophilic or lipophilic form, which are useful as angiotensin II ATI receptor antagonists suitable for transdermal delivery. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: October 22, 2013
    Assignee: Eldrug S.A.
    Inventors: John Matsoukas, Michael Maragoudakis, Dimitrios Vlaxakos
  • PARSTATIN PEPTIDES
    Publication number: 20130150298
    Abstract: The present invention relates to parstatin peptides, compositions comprising parstatin peptides and their use in the treatment of various disorders, including angiogenesis-related diseases, ocular neovascularisation and related disease states, ischemia-reperfusion injury and myocardial-related disease states, and renal disorders.
    Type: Application
    Filed: August 5, 2010
    Publication date: June 13, 2013
    Inventors: Nikos Tsopanoglou, Michael Maragoudakis, Stanley Vinores, Jennifer Strande, Sotirios Gartaganis, Dimitrios Siablis
  • 1,3 AND 1,3,5 SUBSTITUTED IMIDAZOLES AS ANTIHYPERTENSIVES
    Publication number: 20100216854
    Abstract: The present invention provides novel 1,5 and 1,3,5-substituted imidazole compounds of formulas (I), (IIa), (IIIb) in hydrophilic or lipophilic form, which are useful as angiotensin II AT1 receptor antagonists with sympathetic suppressant properties. In particular, the invention provides pharmaceutical compositions containing the pharmacophoric groups of Losartan and Clonidine as well compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases through Renin Angiotensin System (RAS) and Sympathetic System (SS). Alkylated histamine based double action Saltans are lipophilic and can act transdermally.
    Type: Application
    Filed: July 25, 2008
    Publication date: August 26, 2010
    Applicant: Eldrug S.A.
    Inventors: John Matsoukas, Charalambos Gavras, Dimitrios Vlaxakos, Michael Maragoudakis